Sarepta Therapeutics (SRPT) Announces Restructuring and ELEVIDYS Black Box Warning, EMA Recommends Refusal of Marketing Authorization, Securities Class Action Pending - Hagens Berman
Go back to Sarepta Therapeutics (SRPT) Announces Restructuring and ELEVIDYS Black Box Warning, EMA Recommends Refusal of Marketing Authorization, Securities Class Action Pending - Hagens Berman| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 17.26 -0.39 (2.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.65 | 52 Week High | $63.73 | |||
| Open | $17.33 | 52 Week Low | $8.00 | |||
| Day High | $17.80 | P/E | N/A | |||
| Day Low | $17.22 | EPS | $-5.69 | |||
| Volume | 2,259,223 | |||||
